|
C10ORF28 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02339999999523E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.51777999999325E-05 |
| Normal-vs-Stage2 |
9.382000E-03 |
| Normal-vs-Stage3 |
9.422200E-03 |
| Normal-vs-Stage4 |
3.299800E-03 |
| Stage1-vs-Stage2 |
5.892400E-01 |
| Stage1-vs-Stage3 |
3.012600E-01 |
| Stage1-vs-Stage4 |
6.947200E-01 |
| Stage2-vs-Stage3 |
2.912000E-01 |
| Stage2-vs-Stage4 |
4.681200E-01 |
| Stage3-vs-Stage4 |
6.437000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.90919999999828E-05 |
| Normal-vs-AfricanAmerican |
6.15569999999899E-05 |
| Normal-vs-Asian |
4.719900E-03 |
| Caucasian-vs-AfricanAmerican |
6.442200E-02 |
| Caucasian-vs-Asian |
6.059900E-03 |
| AfricanAmerican-vs-Asian |
4.463900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.14879999999029E-05 |
| Normal-vs-Female |
3.93870000000573E-05 |
| Male-vs-Female |
8.826400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.041500E-02 |
| Normal-vs-Age(41-60Yrs) |
4.88389999997452E-07 |
| Normal-vs-Age(61-80Yrs) |
8.389400E-04 |
| Normal-vs-Age(81-100Yrs) |
9.367400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.858400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.092600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.724000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.472300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.056100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.132360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.26070000053369E-07 |
| Normal-vs-Grade 2 |
2.7562000000092E-06 |
| Normal-vs-Grade 3 |
1.402440E-03 |
| Normal-vs-Grade 4 |
3.825900E-02 |
| Grade 1-vs-Grade 2 |
1.296280E-02 |
| Grade 1-vs-Grade 3 |
2.716000E-03 |
| Grade 1-vs-Grade 4 |
7.381100E-03 |
| Grade 2-vs-Grade 3 |
1.960000E-01 |
| Grade 2-vs-Grade 4 |
1.391750E-01 |
| Grade 3-vs-Grade 4 |
6.165400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.62119999999844E-05 |
| Normal-vs-ccB subtype |
2.809000E-04 |
| ccA subtype-vs-ccB subtype |
5.692400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11179999995326E-06 |
| Normal-vs-N1 |
4.214400E-02 |
| N0-vs-N1 |
5.346000E-01 |
|
|
